Assessment of Transforming Growth Factor-β1 in Egyptian Patients with Chronic Hepatitis-C Virus and Hepatocellular Carcinoma

Non-Invasive Markers for Liver Fibrosis in Chronic HCV Patients

Biochemical study of some non invasive markers in liver fibrosis patients.

SERUM MARKERS FOR ASSESSING LIVER FIBROSIS IN EGYPTIAN PATIENTS WITH CHRONIC HEPATITIS B AND C CO-INFECTION VERSUS CHRONIC HEPATITIS C

Serum soluble cluster of differentiation 163 (sCD163), matrix metalloproteinase 9 (MMP9) and cytokeratin 18 (CK18) levels as biomarkers for liver fibrosis in Egyptian chronic hepatitis C patients

Assessment of IL-10 Polymorphism and TGF beta 1 Polymorphism in Egyptian Patients with Chronic Liver Disease

Study of Fibro Q Index as a Non invasive Method to Predict Liver Fibrosis in Chronic Hepatitis C

Estimation of Serum Interleukin-18 and Hs-CRP in Chronic Hepatitis C Infected Patients at Assuit Governorate, Egypt

Albumin- Bilirubin Score as a Non-Invasive Serum Biomarker for Advanced Liver Fibrosis and Cirrhosis in Egyptian Patients with Chronic Hepatitis C Infection: A Case-Control Study

Doppler Ultrasound and Fibroscan Parameters Versus Liver Biopsy ‎in Evaluation of Hepatic Fibrosis in Egyptian Patients with Chronic ‎Hepatitis C‎